A phase II study of neoadjuvant and adjuvant chemotherapy with 5-fluorodeoxyuridine, leucovorin, oxaliplatin and docetaxel in the treatment of previously untreated advanced esophageal adenocarcinoma.
Jpn. J. Clin. Oncol., Apr;41(4):469-76 (2011)
Neoadjuvant, surgery and adjuvant chemotherapy without radiation for esophageal cancer.
Jpn. J. Clin. Oncol., Aug;37(8):590-6 (2007)
Defining the role of surgery for primary gastrointestinal tract melanoma.
J. Gastrointest. Surg., Apr;12(4):731-8 (2008)
Male breast cancer: is the incidence increasing?
Ann. Surg. Oncol., Aug;11(8):751-5 (2004)
Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors.
J. Am. Coll. Surg., Apr;202(4):623-9 (2006)
Results of 23,810 cases of ductal carcinoma-in-situ.
Ann. Surg. Oncol., May;14(5):1638-43 (2007)
Surgical outcomes of gastrointestinal sarcoma including gastrointestinal stromal tumors: a population-based examination.
J. Gastrointest. Surg., Jan;11(1):114-25 (2007)
Are we training our residents to perform open gall bladder and common bile duct operations?
J. Surg. Res., Oct;142(2):246-9 (2007)
A phase II study of irinotecan, high-dose 24-h continuous intravenous infusion of floxuridine and leucovorin (IFLUX) for advanced, previously untreated colorectal cancer.
Anticancer Drugs., Sep;18(8):955-61 (2007)
How many lymph nodes properly stage a periampullary malignancy?
J. Gastrointest. Surg., Jan;12(1):77-85 (2008)
The role of endoscopic ultrasound in assessing tumor response and staging after neoadjuvant chemotherapy for esophageal cancer.
Surg Endosc., Feb;26(2):518-22 (2012)